APO LMV 150 (Lamivudine 150 mg)
Pill with imprint APO LMV 150 is White, Four-sided and has been identified as Lamivudine 150 mg. It is supplied by Apotex Inc..
Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO LMV 150
Lamivudine
- Imprint
- APO LMV 150
- Strength
- 150 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (nrtis)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Inc.
- Inactive Ingredients
-
lactose anhydrous,
crospovidone,
silicon dioxide,
hypromelloses,
hydroxypropyl cellulose (type h),
magnesium stearate,
polyethylene glycol,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 60505-3251 | Apotex Corp. |
| 00904-6583 | Major Pharmaceuticals |
Related Images for "APO LMV 150"
More about lamivudine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
- Other brands
- Epivir, Epivir-HBV
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.